UroGen Pharma Ltd
Biotechnology
Healthcare
URGN
43.10 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
9.44
52 week high
19.20
high
10.20
52 week low
9.27
previous Close
9.66
P/E ratio
market cap
457 M
div yield
0
net incoming
-23.67 M
29.13 %
net profit margin
-93.93 %
58.00 %
operating incoming
-17.55 M
32.10 %
net change in cash
-94.81 M
-207.09 %
cash on hand
125 M
-43.42 %
cost of revenue
2.45 M
10.05 %
top